Endocrine Abstracts

Introduction: There is a long delay between the onset of symptoms and correct diagnosis of acromegaly. This study aimed to explore the potential of hand size as a screening tool of acromegaly. Here we present first results of a new screening project.Method: We measured scan-copies of acromegalics (n=27, 9 women, age 18–84 years) and controls (n=111, 71 women, age 19–81 years) and analyzed surface areas of palm and thenar and m...

Objectives: Acromegaly is associated with elevated cardiovascular morbidity. Medical treatment of acromegaly does not only lead to a normalisation of the somatotroph axis, but can also negatively influence cardiovascular risk factors and comorbidities.Methods: In a cross-sectional study, we evaluated cardiovascular risk markers (glucose, HbA1c, triglycerides, cholesterol, HDL, LDL, lipoprotein a, homocystein, CRP) in relation to biochemical control and m...

Background: In acromegaly, few in vivo data exist on changes of the brain parenchyma as a pathology caused by systemically elevated levels of GH and IGF-1. This is in contrast to neuropsychiatric symptoms such as depression, cognitive impairment, personality changes and pain syndromes that accompany the condition. We aimed at measuring brain tissue volumes and white matter pathology in acromegaly.Methods: Forty-three patients (age 54±14 years...